Cairns Health

Cairns Health successfully expands Luna's adoption in senior living and home care, leveraging the Together by Renee acquisition to enhance medication management and AI vision. Strong market penetration in the growing $43.4B SAM, coupled with strategic partnerships, drives revenue to $30M+ by 2028. This justifies a 15x revenue multiple, leading to a $450M valuation and a 4.5x return on current valuation.

Cairns Health continues to grow Luna's user base at a steady pace, maintaining its moderate competitive moat through patented technology. Revenue grows to ~$15M-$20M by 2028, but competitive pressures from larger incumbents and well-funded startups limit multiple expansion. An exit at a 6x-8x revenue multiple results in a $120M-$160M valuation, offering a modest 20% upside from the current estimated $100M valuation.

Dominant incumbents like Google Health or Amazon expand aggressively into the AI-powered senior care space, commoditizing key features and eroding Cairns Health's market share. Slower-than-expected adoption of Luna and increased customer acquisition costs lead to revenue stagnation or decline. A down round or acquisition at a distressed valuation of $60M or less, combined with a severe preference stack, results in significant loss of common stock value.